Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody-Reference-Cited by-同舟云学术

Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody

Published:2011-08 Issue:2 Volume:49 Page:151-161
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Kostenuik Paul J.,Smith Susan Y.,Jolette Jacquelin,Schroeder Joseph,Pyrah Ian,Ominsky Michael S.

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference38 articles.

1. Evidence that bone resorption precedes bone formation at the cellular level;Takahashi;Henry Ford Hosp. Med. Bull.,1964

2. Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomogus monkeys;Smith;Bone,2003

3. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study;Garnero;J. Bone Miner. Res.,1996

4. Lasofoxifene in postmenopausal women with osteoporosis;Cummings;N. Engl. J. Med.,2010

5. Fracture risk reduction with alendronate in women with osteoporosis: the fracture intervention trial;Black;J. Clin. Endocrinol. Metab.,2000

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the efficacy and safety of a proposed biosimilar QL1206 with reference denosumab in patients with bone metastasis from breast cancer: a subgroup analysis of a randomized, double-blinded phase III study;2024-06-11

2. Twelve Months of Denosumab and/or Alendronate Is Associated With Improved Bone Fatigue Life, Microarchitecture, and Density in Ovariectomized Cynomolgus Monkeys;Journal of Bone and Mineral Research;2023-01-04

3. An Overview of Bone Toxicology;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2023

4. Novel bioactive collagen-polyurethane-pectin scaffolds for potential application in bone regenerative medicine;Applied Surface Science Advances;2022-10

5. Bone Mineral and Organic Properties in Postmenopausal Women Treated With Denosumab for Up to 10 years;Journal of Bone and Mineral Research;2022-03-24